Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Investigator-Sponsored Protocol - Continued Use of Ibalizumab

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
TaiMed Biologics Inc.
Information provided by (Responsible Party):
William J. Towner, Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT01056393
First received: January 22, 2010
Last updated: April 7, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: November 2015
  Estimated Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)